About Danny Huntington

Danny Huntington is a shareholder at Rothwell Figg, whose IP practice includes covers litigation, US and foreign prosecution, licensing, and general client counselling, with a focus on biotechnology and pharmaceuticals. A former chemist for The Gillette Research Institute, Danny was one of the few knowledgeable in both interferences and biotechnology when the US Patent and Trademark Office started declaring patent interferences involving biotechnology. He has handled more than 200 interferences, allowing him to seamlessly transition to handling other post-grant proceedings before the PTAB. Among other organisations, Danny is a member of the Fédération Internationale des Conseils en Propriété Intellectuelle (FICPI), of which he is a president of honour and a member of the Biotechnology Committee.